Call for Expression of Interest (EOI)

The aim of this Call for Expressions of Interest (EOI) is to identify potential industry partners that can contribute to enhancing supply resilience and access to medicines[1] for treatment and/or prevention of postpartum hemorrhage, new malaria treatments and therapeutics for HIV and related co-infections, in Africa by strengthening regional manufacturing and developing the broader supply ecosystem.

The supported interventions for Medicines for Prevention and Treatment of Post-Partum Hemorrhage (PPH)  are co-funded by the European Union under the project “Safe Birth Africa.”

• Download Expression of Interest (EOI)
• EOIs should be submitted here
• Deadline for Questions: 30 July 2024
• Q&A Response Document Released: 10 August 2024

Closing Date: 6 September 2024 (17:00 CET)

Webinar providing potential applicants with more information on the EOI

Date: 17 July 2024 (14:00 CET)

Join via Zoom: https://unitaid.zoom.us/j/99652508236?pwd=z1S7DquT3qBDg76N5yKL3X0PmgYMPJ.1

[1] Invitro diagnostics (IVDs) are currently not in scope. An EOI for IVD manufacturers was published in November 2023. IVD manufacturers can submit their expression of interest here: Expression of interest: strengthening the regional supply of in vitro diagnostics in LMICs.